Table 2 Utilization of publicly available datasets.
Figure (main) | Figure (sub) | Dataset type | Accession number/reference | Samples | Source |
|---|---|---|---|---|---|
Figure 1a–f Figure 2c Figure 3d Figure 4a, b Figure 7c, d | Figure 1a–d Figure 7c | Bulk RNA-seq | GSE136825 | 28 Healthy 42 CRSwNP | GEO Database |
Figure 4a, b | Figure 3a, b Figure 7a–c | Bulk RNA-seq | GSE179269 | 6 Healthy 17 CRSwNP | GEO Database |
Figure 6e, f | – | Bulk RNA-seq | GSE268072 | 5 Resting hNECs 5 IL-4/IL-13 co-stim. hNECs | GEO Database |
Figure 2a–e Figure 3c, e Figure 5b–f Figure 6a–d | Figure 2a, b Figure 3d Figure 5a–f Figure 6a–e | scRNA-seq | HRA000772 | 11 CRSwNP | GSA-Human National Genomics Data Center (NGDC) |
Figure 4f | – | scRNA-seq | Ref. 10 | 2 CRSwNP-NP 4 CRSwNP-IT 3 Healthy-IT | The Alexandria Project |
Figure 6h–j | Figure 6f | scRNA-seq | Ref. 10 | 2 Dupilumab pretreatment 3 Dupilumab post-treatment | The Alexandria Project |